Literature DB >> 18402766

Site-specific modification of positively-charged surfaces on human serum albumin by malondialdehyde.

Takeshi Ishii1, Sohei Ito, Shigenori Kumazawa, Toyo Sakurai, Satoru Yamaguchi, Taiki Mori, Tsutomu Nakayama, Koji Uchida.   

Abstract

Malondialdehyde (MDA), a lipid peroxidation product, reacts with lysine residues in proteins. Human serum albumin (HSA) is a major target of MDA-modification of serum proteins. To identify, the modification sites of HSA by MDA in vitro, MDA-treated HSA was digested with a protease and the resulting peptides were subjected to liquid chromatography-tandem mass spectrometry. We identified six peptides, which contained a N-propenal adduct at Lys136, Lys174, Lys240, Lys281, Lys525, and Lys541, and revealed that Lys525 is the most reactive residue for MDA modification. Analysis of electrostatic surface potential of a 3-D model structure of HSA indicates that Lys525 is located at the center of positively charged grooves. The results of this study indicate that the modification of proteins by lipid-derived aldehydes may be influenced by the electrostatic potential of the protein surface.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18402766     DOI: 10.1016/j.bbrc.2008.03.140

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint.

Authors:  Ted R Mikuls; Michael J Duryee; Rafid Rahman; Daniel R Anderson; Harlan R Sayles; Andrew Hollins; Kaleb Michaud; Frederick Wolfe; Geoffrey E Thiele; Jeremy Sokolove; William H Robinson; Nithya Lingampalli; Anthony P Nicholas; Geoffrey A Talmon; Kaihong Su; Matthew C Zimmerman; Lynell W Klassen; Geoffrey M Thiele
Journal:  Rheumatology (Oxford)       Date:  2017-10-01       Impact factor: 7.580

2.  Oxidative hotspots on actin promote skeletal muscle weakness in rheumatoid arthritis.

Authors:  Maarten M Steinz; Malin Persson; Bejan Aresh; Karl Olsson; Arthur J Cheng; Emma Ahlstrand; Mats Lilja; Tommy R Lundberg; Eric Rullman; Kristina Ängeby Möller; Katalin Sandor; Sofia Ajeganova; Takashi Yamada; Nicole Beard; Björn Cg Karlsson; Pasi Tavi; Ellinor Kenne; Camilla I Svensson; Dilson E Rassier; Roger Karlsson; Ran Friedman; Thomas Gustafsson; Johanna T Lanner
Journal:  JCI Insight       Date:  2019-03-28

3.  Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.

Authors:  Baohai Shao; Subramaniam Pennathur; Ioanna Pagani; Michael N Oda; Joseph L Witztum; John F Oram; Jay W Heinecke
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

4.  Development of Diagnostic Fragment Ion Library for Glycated Peptides of Human Serum Albumin: Targeted Quantification in Prediabetic, Diabetic, and Microalbuminuria Plasma by Parallel Reaction Monitoring, SWATH, and MSE.

Authors:  Arvind M Korwar; Garikapati Vannuruswamy; Mashanipalya G Jagadeeshaprasad; Ramesha H Jayaramaiah; Shweta Bhat; Bhaskaran S Regin; Sureshkumar Ramaswamy; Ashok P Giri; Viswanathan Mohan; Muthuswamy Balasubramanyam; Mahesh J Kulkarni
Journal:  Mol Cell Proteomics       Date:  2015-05-28       Impact factor: 5.911

5.  Effect of protein modification by malondialdehyde on the interaction between the oxygen-evolving complex 33 kDa protein and photosystem II core proteins.

Authors:  Yasuo Yamauchi; Yukihiro Sugimoto
Journal:  Planta       Date:  2010-02-16       Impact factor: 4.116

6.  Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.

Authors:  Geoffrey M Thiele; Michael J Duryee; Daniel R Anderson; Lynell W Klassen; Stephen M Mohring; Kathleen A Young; Dathe Benissan-Messan; Harlan Sayles; Anand Dusad; Carlos D Hunter; Jeremy Sokolove; William H Robinson; James R O'Dell; Anthony P Nicholas; Dean J Tuma; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

7.  Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.

Authors:  Satu Hyvärinen; Koji Uchida; Markku Varjosalo; Reija Jokela; T Sakari Jokiranta
Journal:  J Biol Chem       Date:  2013-12-16       Impact factor: 5.157

8.  iCar-PseCp: identify carbonylation sites in proteins by Monte Carlo sampling and incorporating sequence coupled effects into general PseAAC.

Authors:  Jianhua Jia; Zi Liu; Xuan Xiao; Bingxiang Liu; Kuo-Chen Chou
Journal:  Oncotarget       Date:  2016-06-07

9.  Protein modification by adenine propenal.

Authors:  Sarah C Shuck; Orrette R Wauchope; Kristie L Rose; Philip J Kingsley; Carol A Rouzer; Steven M Shell; Norie Sugitani; Walter J Chazin; Irene Zagol-Ikapitte; Olivier Boutaud; John A Oates; James J Galligan; William N Beavers; Lawrence J Marnett
Journal:  Chem Res Toxicol       Date:  2014-09-24       Impact factor: 3.739

10.  Evidence that endogenous formaldehyde produces immunogenic and atherogenic adduct epitopes.

Authors:  Jun Nakamura; Takasumi Shimomoto; Leonard B Collins; Darcy W Holley; Zhenfa Zhang; Jenna M Barbee; Vyom Sharma; Xu Tian; Tomohiro Kondo; Koji Uchida; Xianwen Yi; Diana O Perkins; Monte S Willis; Avram Gold; Scott J Bultman
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.